menu search

Investor alert: abbott cooper pllc announces investigation into gossamer bio, inc.; urges gossamer stockholders to contact abbott cooper regarding their legal rights

STAMFORD, Conn., Nov. 01, 2023 (GLOBE NEWSWIRE) — Abbott Cooper PLLC is investigating gossamer Bio, I...

November 2, 2023, 3:27 am

gossamer bio to present results of torrey fri sub-study at the european respiratory society international congress 2023

SAN DIEGO--(BUSINESS WIRE)--gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical compa...

September 7, 2023, 7:44 am

gossamer bio stock struggles from lack of near-term catalysts: analysts

Shares of gossamer Bio fell Thursday, and the company earned a downgrade from analysts at UBS.  Citing...

July 27, 2023, 3:04 pm

gossamer bio to hold conference call with pah experts to discuss prosera phase 3 design and interim torrey ole results

SAN DIEGO--(BUSINESS WIRE)--gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical compa...

July 24, 2023, 4:16 pm

gossamer bio: merck's stellar data impressive, but game not over for seralutinib

Merck's Sotatercept showed significant improvements in PAH patients in Phase 3 STELLAR trial with a primary endpoint of improvements in pulmonary vasc...

April 2, 2023, 4:12 am

gossamer: disappointing phase 2 results but too cheap to ignore

gossamer's TORREY showed stat sig PVR improvement, but the 6MWD was under what investors were hoping fo...

January 30, 2023, 4:48 am

gossamer bio (goss) upgraded to buy: what does it mean for the stock?

gossamer Bio (GOSS) might move higher on growing optimism about its earnings prospects, which is reflec...

January 4, 2023, 1:32 pm

gossamer bio (goss) loses -13.56% in 4 weeks, here's why a trend reversal may be around the corner

gossamer Bio (GOSS) is technically in oversold territory now, so the heavy selling pressure might have ...

January 4, 2023, 11:17 am

Shareholder alert: pomerantz law firm investigates claims on behalf of investors of gossamer bio, inc. – goss

NEW YORK, Dec. 24, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of g...

December 25, 2022, 2:15 am

gossamer bio: buying the savage dip after a trial 'win' may be unwise

gossamer Bio, Inc.'s lead candidate - Seralutinib, indicated for Pulmonary Arterial Hypertension - met ...

December 8, 2022, 1:27 pm

gossamer bio tumbles as hypertension drug underperforms rival product in phase 2 trial

gossamer Bio Inc stock lost three quarters of its value today as the market questioned the performance...

December 6, 2022, 2:54 pm

Why is gossamer bio (goss) stock down over 70% today?

gossamer Bio (NASDAQ: GOSS ) is one of the top-trending tickers on social media today, and its shares a...

December 6, 2022, 10:51 am

gossamer bio's stock falls 64% on findings for phase 2 study for hypertension drug

Shares of gossamer Bio Inc. GOSS, +2.99% plunged 64.5% in premarket trading on Tuesday after Wall Stree...

December 6, 2022, 8:19 am

What makes gossamer bio (goss) a new buy stock

gossamer Bio (GOSS) might move higher on growing optimism about its earnings prospects, which is reflec...

November 8, 2022, 1:32 pm

gossamer bio pulls plug on mid-stage ulcerative colitis program

gossamer Bio Inc (NASDAQ: GOSS) shares are falling after announcing topline results from its Phase 2...

April 25, 2022, 9:06 am

gossamer bio to announce fourth quarter and full-year 2021 financial results and host conference call and webcast on march 3, 2022

SAN DIEGO--(BUSINESS WIRE)--gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical compa...

February 28, 2022, 7:01 am

gossamer bio to announce fourth quarter and full-year 2021 financial results and host conference call and webcast on march 3, 2022

SAN DIEGO--(BUSINESS WIRE)--gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical compa...

February 28, 2022, 7:01 am

gossamer bio to announce fourth quarter and full-year 2021 financial results and host conference call and webcast on march 3, 2022

SAN DIEGO--(BUSINESS WIRE)--gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical compa...

February 28, 2022, 7:01 am


Search within

Pages Search Results: